Highlight
– Early-onset dementia (EOD) leads to significant productivity and income loss starting up to 15 years before formal diagnosis.
– Different EOD subtypes manifest distinct patterns and timing of income decline, with frontotemporal dementia showing earlier loss than Alzheimer disease.
– Cumulative productivity losses per patient are substantial, emphasizing the long-term socioeconomic burden of EOD.
– Enhanced early recognition and subtype-specific interventions could mitigate the financial and societal impact of EOD.
Study Background
Early-onset dementia (EOD), defined by onset before 65 years of age, presents a unique and substantial healthcare challenge due to its interference with individuals at a productive age. Unlike late-onset dementia, EOD affects people typically in their prime working years, leading to pronounced impacts on employment, income, and family dynamics. Despite the rising awareness of EOD’s clinical heterogeneity—with subtypes including Alzheimer disease (AD), frontotemporal dementia (FTD) spectrum disorders, α-synucleinopathies (α-SYNUs), and other etiologies—comprehensive long-term socioeconomic data remain scarce. Understanding income trajectories and productivity loss before diagnosis is crucial for informing health policy, supporting patients, and optimizing resource allocation.
Study Design
This investigation was a population-based retrospective longitudinal cohort study encompassing all EOD cases diagnosed from 2010 to 2021 within the referral areas of Kuopio University Hospital and Oulu University Hospital in Finland. The study cohort included 793 patients with confirmed EOD diagnoses verified through clinical data review. For comparison, 10 age- and sex-matched controls per case (totaling 7,926 controls) were randomly selected from national registries.
Demographic details, educational background, and comorbidity profiles were extracted from national health and administrative databases. Annual gross income data were obtained from Statistics Finland’s tax records, providing an objective measure of economic productivity. The Human Capital Approach was employed to quantify productivity loss by modeling income differences relative to controls. A generalized estimating equation (GEE) regression model analyzed panel data spanning from 15 years before up to the year of diagnosis, enabling robust longitudinal insights.
Key Findings
The study population had a balanced sex distribution (50.4% women) with a mean age of 59.6 years. Among the 793 patients, 421 had AD, 179 had FTD spectrum disorders, 46 had α-SYNUs (including dementia with Lewy bodies, Parkinson’s disease dementia), and 147 had other causes—predominantly vascular and mixed dementias.
Longitudinal Income and Productivity Loss
Compared with matched controls, EOD patients exhibited a clear, progressive decline in annual gross income starting well before clinical diagnosis. This trend indicates an insidious onset of functional impairment affecting work capacity.
Subtype-Specific Patterns
- Alzheimer Disease (AD): Productivity loss became statistically significant 6 years prior to diagnosis, starting at €2,767 (95% CI 18–5,515; p=0.024), escalating to €11,431 (95% CI 8,676–14,184; p<0.001) at the time of diagnosis.
- Frontotemporal Dementia (FTD): Losses appeared earlier, 11 years before diagnosis, with €4,799 (95% CI 433–9,166; p=0.031), and increased to €16,116 (95% CI 11,671–20,561; p<0.001) at diagnosis, reflecting the often early behavioral and executive dysfunction impacting employment.
- α-synucleinopathies (α-SYNUs): Income differences were inconsistent over time but significant at diagnosis with €11,284 loss (95% CI 2,574–19,993; p=0.011), indicating later, perhaps more abrupt, work impairment.
- Other EOD subtypes: This heterogeneous group showed consistently elevated productivity losses throughout the 15-year prediagnostic period, for example, €8,744 at diagnosis (p<0.001), likely reflecting vascular contributions to gradual functional decline.
The cumulative mean productivity loss per patient over 15 years before diagnosis was an estimated €74,577 (range €46,423-€102,732), illustrating the profound economic burden borne by individuals and society.
Expert Commentary
This study robustly demonstrates that the socioeconomic impact of EOD predates clinical diagnosis by over a decade, varying significantly by dementia subtype. The earlier onset of productivity loss in FTD aligns with its characteristic early executive and behavioral symptoms that can disrupt occupational functioning long before memory deficits arise. Conversely, AD shows a more gradual decline starting closer to diagnosis, consistent with its typical clinical progression.
The use of national tax records and matched controls provides objective and precise estimates of income loss, overcoming biases common in self-reported or cross-sectional studies. By quantifying losses with the Human Capital Approach, this research underscores the extended duration and magnitude of workforce disengagement in EOD.
Nevertheless, limitations include potential unmeasured confounding factors such as premorbid employment status, informal caregiving roles, and psychosocial factors influencing work continuation. The heterogeneity within the “other EOD” group also suggests the need for further subtype-specific economic investigations.
Clinically, these findings support the need for earlier identification, targeted vocational rehabilitation, and social support interventions tailored to specific EOD phenotypes to mitigate their socioeconomic impact. Policymakers should consider the extended prediagnostic economic losses when planning healthcare services and disability benefits.
Conclusion
Early-onset dementia inflicts a substantial and progressive economic toll starting up to 15 years before diagnosis, with variation in timing and magnitude between subtypes. This extended preclinical burden emphasizes the importance of heightened clinical vigilance, timely diagnosis, and comprehensive multidisciplinary care pathways to preserve productivity and support affected individuals and families. Future research should explore cost-effective early intervention strategies and further delineate economic trajectories across diverse EOD populations.
Funding and ClinicalTrials.gov Registration
This study was conducted as part of the DEGE-RWD-research project coordinated by Neurocenter Finland. The protocol is registered at ClinicalTrials.gov (identifier: NCT06209515). Funding sources were not detailed in the publication.
References
1. Kivisild A, et al. Long-Term Income and Productivity Losses in Individuals With Early-Onset Dementia: Evidence From 15 Years Preceding the Diagnosis. Neurology. 2026 Jul 8;107(3):e218268. PMID: 42418748.
2. Livingston G, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413-446.
3. Harvey PD. Early identification and treatment of behavioral and psychological symptoms of frontotemporal dementia to improve functional outcomes. J Clin Psychiatry. 2019;80(6):19ac12856.
4. Gustavsson A, et al. Cost of Alzheimer’s disease and dementia in Europe—a review of the evidence, and methodological considerations. Pharmacoeconomics. 2011;29(6):455-468.
